There is a new case of crime involving a private pathology group practice. In Stockton, California, the Stockton Record reported on August 9 that pathologist Elvira Milano, M.D., was expected to post bond and be released from jail on that date. She faces charges of embezzlement while serving as chief financial officer of Delta Pathology Associates Medical Group (DPAMG) in Stockton. She was terminated on March 29, 2013, reported the Record, which also stated that court records indicate, “Milano used her control of the payroll to steal $503,202 from Delta Pathology from 2007-13. She is accused of taking $432,000 in excess payments in 2011 alone. In one 56-day span that year, she is alleged to have paid her- self $421,000. Her annual salary that year was $226,200.” Milano faces multiple charges in San Joaquin County Superior Court, with the possibility of jail time if convicted, stated the Record.
MORE ON: Milano
The Stockton Record also noted that Milano and another pathologist at DPAMG were co-defendants in a 2011 civil case involving their pathology group and Integrated Pathology Services of Stockton. As reported by the Lodi News, the plaintiffs were awarded a $2.8 million judgement for breach of contract and unfair business practices. The Lodi News said that Integrated had provided technical pathology services to DPAMG, but had not been paid for those services.
- Matthew McManus, M.D., Ph.D., was appointed President and CEO of Assuragen, Inc., of Austin, Texas. McManus has served as an executive at PrimeraDx, and Cleveland Clinical Laboratories.
- Al H. Sirmon, CPA, President of PSA, a McKesson Company, retired at the end of July. Prior to joining PSA, he held management positions with a clinical laboratory and Pee Dee Pathology, based in Florence, South Carolina.
- Chris Christopher has retired from his position as Vice President of Global Customer Solutions at Siemens Healthcare, effective at the end of July. Christopher held executive positions at Dade Behring, Dade International, and Baxter.
- HemoSonics, LLC, of Charlottesville, Virginia announced that Timothy J. Fischer is the new President and CEO. Fischer has previously served with LipoScience, Becton, Dickinson, TriPath Oncology, Ventana Medical Systems, and Organon Teknika
Dark Daily Update
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about…
…why more patients are becoming angry as health insurers refuse to pay for expensive genetic tests. These patients see the genetic test as a last resort for accurate diagnosis and selection of a therapy that might help them.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.